MapLight Therapeutics, Inc. MPLT Ratios & Valuation
| Q1 '26 | Q4 '25 | Q3 '25 | Q1 '25 | Q4 '24 | ||
|---|---|---|---|---|---|---|
| Liquidity | ||||||
| Current ratio | 22.9×+2.9× | 20×+6.8× | 13.2×— | —— | 7.2×— | |
| Quick ratio | 22.9×+2.9× | 20×+6.8× | 13.2×— | —— | 7.2×— | |
| Cash ratio | 3.9×+1.0× | 2.9×-0.6× | 3.5×— | —— | 2.4×— | |
| Leverage | ||||||
| Debt-to-equity | 0×0.0× | 0×— | —— | —— | —— | |
| Debt-to-assets | 0×0.0× | 0×0.0× | 0×— | —— | 0×— | |
| Per Share | ||||||
| Book value per share | $8.83-83.3% | $52.80+115% | -$346.57-22.3% | -$283.39-7.7% | -$263.02-15.7% | |
| Valuation | ||||||
| Market capitalization | $1.39B+100% | $796.98M— | —— | —— | —— | |
| Enterprise value | $1.34B— | $756.05M— | —— | —— | —— | |
| Price / book | 3.5×— | 1.7×— | —— | —— | —— | |
| Earnings yield | -14.4%— | -20.2%— | —— | —— | —— |
Questions, answered.
- Where do MapLight Therapeutics, Inc. 's ratios come from?
- Every ratio is computed from MapLight Therapeutics, Inc. 's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.